Brain Case

Brain Case is a leading biotechnology company specialising in the development, production and optimisation of viral vectors for use in gene therapy, cell therapy and medical research. With a clear focus on innovation and excellence in biotechnology, BrainCase offers customised solutions for the pharmaceutical industry, research institutions and biotech companies worldwide.

Brain Case has particularly focussed on the development and production of adeno-associated viruses (AAV), which are used in gene therapy to provide precise and targeted treatments for genetic diseases. AAV technology is known for its high safety and efficiency in gene therapy and is increasingly being used for clinical applications. The company ensures that all vectors developed meet the highest quality standards to achieve the best possible therapeutic results.

Brain Case's service portfolio ranges from the development and design of viral vectors to production under GMP (Good Manufacturing Practice) conditions and scalable production processes for clinical trials. In addition, all manufacturing processes and productions are accompanied by comprehensive quality controls that include all relevant tests such as virus quantification, sterility tests and purity analyses.

The company was founded by Dr Yuto Takahashi, an expert in the field of virology and genetics. Dr Takahashi has more than 15 years of experience in biotechnological research and development. Prior to founding BrainCase, he worked in leading international research institutes and was instrumental in the development of new technologies in the field of viral vectors.

Search for products by Brain Case

Brain Case products by Product Category

• 
  Viral Expression
• 
  All Products